Detalhe da pesquisa
1.
Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability.
Biomedicines
; 10(5)2022 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625776